Hydroxylated, Hydroxymethylated, Dihydroxylated, and Trihydroxylated Cyclosporine Metabolites Can Be Nephrotoxic in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Hydroxylated, Hydroxymethylated, Dihydroxylated, and Trihydroxylated Cyclosporine Metabolites Can Be Nephrotoxic in Kidney Transplant Recipients

Published:2016-06 Issue:5 Volume:48 Page:1551-1555
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Hryniewiecka E.,Żegarska J.,Żochowska D.,Jaźwiec R.,Borowiec A.,Samborowska E.,Tszyrsznic W.,Dadlez M.,Pączek L.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference25 articles.

1. Consensus document: Hawk’s Cay meeting on therapeutic drug monitoring of cyclosporine;Kahan;Clin Chem,1990

2. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus;Akhlaghi;Ther Drug Monit,2012

3. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of cyclosporine A and its three metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients;Brozmanowa;J Sep Sci,2010

4. Determination of cyclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography–tandem mass spectrometry;Falck;J Chromatogr B,2007

5. Correlations between calcineurin phosphatase inhibition and cyclosporine metabolites concentrations in kidney transplant recipients: implications for immunoassays;Karamperis;Basic Clin Pharmacol Toxicol,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a novel UPLC‑HRMS method for human whole‑blood cyclosporine and comparison with a CMIA immunoassay;Experimental and Therapeutic Medicine;2021-01-07

2. Higher Concentrations of Cyclosporine Metabolites in Liver Transplant Recipients With a History of Viral and Bacterial Infections;Transplantation Proceedings;2020-10

3. Lack of Relationship Between Renal Function and Genetic Variants of CYP3A4, CYP3A5, MDR1, MRP2, UGT1A9, UGT1A8, and UGT2B7 in Patients After Liver Transplantation in a 2-Year Follow-up;Transplantation Proceedings;2020-10

4. Worsening of Kidney Transplant Function During 2-Year Follow-up Is Associated With the Genetic Variants of CYP3A4, MDR1, and UGT1A9;Transplantation Proceedings;2020-10

5. Low Content of Cyclosporine A and Its Metabolites in the Colostrum of Post-Transplant Mothers;Nutrients;2020-09-04